OpGen Inc (OPGN): FDA clearance doc image Gene Panel. FDA...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	5
Posts	563
Boards Moderated	0
Alias Born	08/19/2020

chillswills37

Re: None

Monday, 10/04/2021 4:40:17 PM

Monday, October 04, 2021 4:40:17 PM

FDA clearance doc image Gene Panel. FDA decision on Thursday September 30, 2021. OPGN PR is dated Monday October 4, 2021.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent OPGN News

OpGen Provides Update on Business Operations and Strategic Opportunities • GlobeNewswire Inc. • 04/29/2024 08:05:00 PM
OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K • GlobeNewswire Inc. • 04/23/2024 08:15:00 PM
Shares Rip In Reaction To Activist Investor Becoming CEO • AllPennyStocks.com • 03/26/2024 08:20:00 PM
OpGen Announces Acquisition of Preferred Stock by David Lazar • GlobeNewswire Inc. • 03/25/2024 08:05:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 09:30:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 12:30:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 09:30:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:58:03 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:37:15 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/24/2023 05:15:18 AM
OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/14/2023 09:30:00 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/13/2023 09:59:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 09:30:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 08:30:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 08:30:09 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/13/2023 09:18:03 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/13/2023 09:17:02 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/13/2023 09:15:31 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/13/2023 09:14:21 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/13/2023 09:13:12 PM
OpGen Enters Into Warrant Inducement Transaction for up to $11.2 Million in Gross Proceeds • GlobeNewswire Inc. • 10/12/2023 04:32:28 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 08:40:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 08:30:10 PM
Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 09/28/2023 08:24:56 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:30:09 PM

More OPGN News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover